Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19772682 | 0.78 | ADORA2A (0.32) | — | |
| SCHEMBL2757590 | 0.75 | L3MBTL1 (0.52) | L3MBTL1 | |
| SCHEMBL11967316 | 0.71 | L3MBTL1 (0.40) | L3MBTL1 | |
| SCHEMBL20159323 | 0.71 | L3MBTL1 (0.36) | L3MBTL1 | |
| SCHEMBL24424367 | 0.71 | L3MBTL1 (0.37) | L3MBTL1 | |
| SCHEMBL20844624 | 0.71 | MAPT (0.30) | — | |
| SCHEMBL19219034 | 0.71 | ADORA3 (0.32) | — | |
| SCHEMBL19221422 | 0.70 | F2 (0.34) | — | |
| SCHEMBL25574059 | 0.70 | L3MBTL1 (0.39) | L3MBTL1 | |
| SCHEMBL22795785 | 0.68 | L3MBTL1 (0.34) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170226270-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226270-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | GNA11, THEM6, TXN2 | L3MBTL1 2920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.